MABLINK BIOSCIENCE
1Patents
1Active
1Granted
51Portfolio score
Filing activity: Oct 2, 2024 → Oct 2, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12419964B2 | Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.